Featured
-
-
Article
| Open AccessHigh expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
- Shiqin Liu
- , Sarah J. Hawley
- & Tanya Stoyanova
-
Article
| Open AccessImpact of radiation doses on clinical relapse of biochemically recurrent prostate cancer after prostatectomy
- Seiya Takano
- , Natsuo Tomita
- & Akio Hiwatashi
-
Article
| Open AccessAssociation between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters
- Paul Vinu Salachan
- , Benedicte Parm Ulhøi
- & Karina Dalsgaard Sørensen
-
Article
| Open AccessLong-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensity-modulated radiotherapy for prostate cancer
- Bong Kyung Bae
- , Ji Eun Kim
- & Won Park
-
Article
| Open AccessInvestigating the prognostic value of mTORC1 signaling in bladder cancer via bioinformatics evaluation
- Xin Yu
- , Wenge Li
- & Juanjuan Li
-
Article
| Open AccessIdentification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer
- Xiaoxu Chen
- , Zheng Qin
- & Haitao Wang
-
Article
| Open AccessAssociation of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis
- Qiheng Li
- , Jiang Zhu
- & Chunmei Zhang
-
Article
| Open AccessEnhancing the image quality of blue light cystoscopy through green-hue correction and fogginess removal
- Shuang Chang
- , Micha E. Bermoy
- & Audrey K. Bowden
-
Article
| Open AccessA Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
- Lulu Zhang
- , Yulei Li
- & Ke Zhu
-
Article
| Open AccessEvaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs
- Marcelo Monte Mor Rangel
- , Laís Calazans Menescal Linhares
- & Andrigo Barboza de Nardi
-
Article
| Open AccessNucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
- Aurel Prosz
- , Haohui Duan
- & Zoltan Szallasi
-
Article
| Open AccessLeveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma
- Xi Zhang
- , Mingcong Zhang
- & Ninghong Song
-
Article
| Open AccessRisk of secondary malignancy following radiation therapy for prostate cancer
- Tenaw Tiruye
- , Rowan David
- & Kerri Beckmann
-
Article
| Open AccessAddressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer
- Balint Kovacs
- , Nils Netzer
- & Klaus H. Maier-Hein
-
Article
| Open AccessTumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses
- YaFei Li
- , Yi Liu
- & Nan Liu
-
Article
| Open AccessScreening for a practical method to monitor the status of patients with metastatic bladder cancer at the circulating cell-gene level
- Ryota Ogura
- , Saya Ito
- & Osamu Ukimura
-
Article
| Open AccessProstate cancer treatment in Portugal: a nationwide analysis
- Francisco Botelho
- , Rui Lopes
- & Nuno Lunet
-
Article
| Open AccessImpact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer
- Emma B. Hansen
- , Questa Karlsson
- & Karina D. Sørensen
-
Article
| Open AccessStatin use and outcomes of oncological treatment for castration-resistant prostate cancer
- A. I. Peltomaa
- , K. Talala
- & T. J. Murtola
-
Article
| Open AccessDevelopment of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive
- Zi-He Peng
- , Juan-Hua Tian
- & Zhao-Lun Li
-
Article
| Open AccessMED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs
- Rachel Ruoff
- , Hannah Weber
- & Michael J. Garabedian
-
Article
| Open AccessMicrovascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
- Astrid Børretzen
- , Lars A. R. Reisæter
- & Ole J. Halvorsen
-
Article
| Open AccessDevelopment and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer
- Zhaoxia Zhang
- , Qian Cai
- & Chenghao Zhanghuang
-
Article
| Open AccessUntargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients
- Carlo Cattrini
- , Marcello Manfredi
- & Alessandra Gennari
-
Article
| Open AccessQuantitative [68Ga]Ga-PSMA-11 PET biomarkers for the analysis of lesion-level progression in biochemically recurrent prostate cancer: a multicentre study
- Jake Kendrick
- , Roslyn J. Francis
- & Martin A. Ebert
-
Article
| Open AccessNatural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
- A. H. Zedan
- , L. Nederby
- & T. F. Hansen
-
Article
| Open AccessThe role of GCNT1 mediated O-glycosylation in aggressive prostate cancer
- Kirsty Hodgson
- , Margarita Orozco-Moreno
- & Jennifer Munkley
-
Article
| Open AccessHuman papillomavirus and prostate cancer: systematic review and meta-analysis
- Irina A. Tsydenova
- , Marina K. Ibragimova
- & Nikolai V. Litviakov
-
Article
| Open AccessTreatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
- Yuta Inoue
- , Takeshi Yamada
- & Osamu Ukimura
-
Article
| Open AccessFunctional consequences of A-to-I editing of miR-379 in prostate cancer cells
- Gjendine Voss
- , James R. Cassidy
- & Yvonne Ceder
-
Article
| Open AccessXpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
- Johannes Breyer
- , Markus Eckstein
- & Maximilian C. Kriegmair
-
Article
| Open AccessLongitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression
- Yozo Mitsui
- , Fumito Yamabe
- & Koichi Nakajima
-
Article
| Open AccessThe impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
- Lilian Marie Boll
- , Júlia Perera-Bel
- & Joaquim Bellmunt
-
Article
| Open AccessIdentification of microRNA editing sites in clear cell renal cell carcinoma
- Yulong Liu
- , Shiyong Guo
- & Yun Zheng
-
Article
| Open AccessDuality of the SVIL expression in bladder cancer and its correlation with immune infiltration
- Zhenyu Nie
- , Na Guo
- & Shufang Zhang
-
Article
| Open AccessDynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
- Joanna Lazniewska
- , Ka Lok Li
- & Douglas A. Brooks
-
Article
| Open AccessRelationship between testosterone and male bladder cancer
- Wei Tan
- , Liang Gao
- & Zili Hu
-
Article
| Open AccessSpecific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis
- Rui Guo
- , Luyao Wang
- & Zhao Yang
-
Article
| Open AccessImpact of delivery time factor on treatment time and plan quality in tomotherapy
- Takayuki Yagihashi
- , Tatsuya Inoue
- & Hironori Nagata
-
Article
| Open AccessHomologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
- Nada Albarakati
- , Hanin Al-Ghamdi
- & Alaa Alshareeda
-
Article
| Open AccessComprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
- Wenbin Tang
- , Zhiyuan Shi
- & Junkai Wang
-
Article
| Open AccessMR imaging features to predict the type of bone metastasis in prostate cancer
- Hiroaki Koyama
- , Ryo Kurokawa
- & Osamu Abe
-
Article
| Open AccessRecurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features
- Shuya Matsubara
- , Akira Saito
- & Yoshio Ohno
-
Article
| Open AccessThe genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies
- K. de Joode
- , W. S. van de Geer
- & A. A. M. van der Veldt
-
Article
| Open AccessCancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time
- Amama Ali
- , Daniel L. Adams
- & Thai H. Ho
-
Article
| Open AccessTumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy
- Ayumi Fujimoto
- , Shinichi Sakamoto
- & Tomohiko Ichikawa
-
Article
| Open AccessAn oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
- Hideto Ueki
- , Koichi Kitagawa
- & Toshiro Shirakawa
-
Article
| Open AccessAnalysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program
- Felipe Andrés Cordero da Luz
- , Camila Piqui Nascimento
- & Marcelo José Barbosa Silva
-
Article
| Open AccessUntargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry
- Joanna Nizioł
- , Krzysztof Ossoliński
- & Tomasz Ruman